Participant | Cohort | Age | Sex | Race | BMI |
---|---|---|---|---|---|
SK-010 | Acute COVID-19 | 36-40 | Female | Asian | NA |
SK-011 | Acute COVID-19 | 56-60 | Female | Caucasian | 35.7 |
SK-012 | Acute COVID-19 | 41-45 | Male | Caucasian | 24.7 |
SK-013 | Acute COVID-19 | 66-65 | Male | NA | NA |
SK-014 | Acute COVID-19 | 51-55 | Female | Asian | NA |
CV-00 1 | mRNA vaccine | 36-40 | Male | Asian | 28.4 |
CV-003 | mRNA vaccine | 31-35 | Male | Asian | 27.9 |
CV-011 | mRNA vaccine | 36-40 | Male | Caucasian | 28.6 |
CV-012 | mRNA vaccine | NA | NA | Asian | 28.7 |
CV-022 | mRNA vaccine | 41-45 | Male | Caucasian | 22.4 |
CV-053 | mRNA vaccine | 46-50 | Female | African-American | NA |
CV-056 | mRNA vaccine | 51-55 | Female | Caucasian | 25.4 |
SK-007 | HC | 36-40 | Female | Caucasian | 20.4 |
SK-008 | HC | 36-40 | Female | Caucasian | 28.6 |